Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL3356 Target Snapshot

Cytochrome P450 1A2 · SINGLE PROTEIN · Homo sapiens

24,030Compounds
2,453Assays
47Approved Drugs
6,570.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-14

Protein identity stays anchored to UniProt P05177. Use UniProt P05177 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt P05177 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-14
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats Cytochrome P450 1A2 as ChEMBL target CHEMBL3356, mapped to UniProt P05177. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
Cytochrome P450 1A2
SINGLE PROTEIN · Homo sapiens
As of 2026-09-14
ChEMBL target ID
CHEMBL3356
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-14
www.ebi.ac.uk
UniProt accession
P05177
Cytochrome P450 1A2
UniProt accession via ChEMBL component mapping As of 2026-09-14
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-14
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether Cytochrome P450 1A2 is the right protein anchor across sources, using UniProt P05177 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelCytochrome P450 1A2
UniProt AccessionP05177
Component TypeProtein
Sequence Length516 aa

Cytochrome P450 1A2

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as Cytochrome P450 1A2, mapped to UniProt P05177. Sequence length is 516 aa.

Mapped IDP05177
Review nameCytochrome P450 1A2
OrganismHomo sapiens
Clinical Profile

Clinical Phase Distribution

47
Approved
13
Phase III
22
Phase II
9
Phase I
2
Phase 0.5
Assay Mix

Activity Type Distribution

IC505,647.0
KI892.0
EC5031.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL5279681 9.9 IC50 0.125 Preclinical
CHEMBL4447260 8.82 IC50 1.5 Preclinical
CHEMBL283196 8.7 IC50 2.0 Preclinical
CHEMBL1223034 8.57 IC50 2.7 Preclinical
CHEMBL4456952 8.39 IC50 4.1 Preclinical
CHEMBL16073 8.31 IC50 4.9 Approved
CHEMBL4282750 8.22 Ki 6.0 Preclinical
CHEMBL112532 8.15 IC50 7.0 Preclinical
CHEMBL279564 8.15 IC50 7.0 Preclinical
CHEMBL512079 8.05 IC50 9.0 Preclinical
Distribution

pChEMBL Value Distribution

356
5.0
278
5.5
228
6.0
149
6.5
111
7.0
77
7.5
19
8.0
3
8.5
0
9.0
1
9.5
pChEMBL
Approved Drugs

Approved Drugs

ALOSETRON
CHEMBL1110
Approved 2000
LEFLUNOMIDE
CHEMBL960
Approved 1998
NISOLDIPINE
CHEMBL1726
Approved 1995
SULCONAZOLE
CHEMBL1221
Approved 1985
ECONAZOLE
CHEMBL808
Approved 1982
TANNIC ACID
CHEMBL506247
Approved 1982
NIFEDIPINE
CHEMBL193
Approved 1981
THIABENDAZOLE
CHEMBL625
Approved 1967
METHOXSALEN
CHEMBL416
Approved 1954
PRIMAQUINE
CHEMBL506
Approved 1952
Assay Landscape

Assay Landscape

2,453
Total Assays
1,488
Tested Compounds
4
Assay Types
ADME — 2,402 assays, 1,488 compounds
BAO Format Assays Compounds Avg pChEMBL
single protein format 1,503 897 5.6
microsome format 524 297 5.4
assay format 217 189 5.8
cell-based format 106 50 6.1
tissue-based format 44 10 5.3
cell membrane format 8 45 6.4
Binding — 49 assays, 140 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 18 64 5.5
single protein format 18 25 5.4
tissue-based format 5 4 5.2
cell-based format 4 42 6.1
microsome format 3 1 6.2
cell membrane format 1 4 7.3
Functional — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
assay format 1 0
Toxicity — 1 assays, 0 compounds
BAO Format Assays Compounds Avg pChEMBL
microsome format 1 0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine